IBDEI1SM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30019,0)
 ;;=C65.9^^135^1372^148
 ;;^UTILITY(U,$J,358.3,30019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30019,1,3,0)
 ;;=3^Malig Neop Renal Pelvis,Unspec
 ;;^UTILITY(U,$J,358.3,30019,1,4,0)
 ;;=4^C65.9
 ;;^UTILITY(U,$J,358.3,30019,2)
 ;;=^5001253
 ;;^UTILITY(U,$J,358.3,30020,0)
 ;;=C50.912^^135^1372^129
 ;;^UTILITY(U,$J,358.3,30020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30020,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,30020,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,30020,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,30021,0)
 ;;=C50.911^^135^1372^151
 ;;^UTILITY(U,$J,358.3,30021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30021,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,30021,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,30021,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,30022,0)
 ;;=C50.919^^135^1372^121
 ;;^UTILITY(U,$J,358.3,30022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30022,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,30022,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,30022,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,30023,0)
 ;;=C62.90^^135^1372^159
 ;;^UTILITY(U,$J,358.3,30023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30023,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,30023,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,30023,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,30024,0)
 ;;=D03.9^^135^1372^161
 ;;^UTILITY(U,$J,358.3,30024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30024,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,30024,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,30024,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,30025,0)
 ;;=C45.0^^135^1372^162
 ;;^UTILITY(U,$J,358.3,30025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30025,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,30025,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,30025,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,30026,0)
 ;;=C90.01^^135^1372^164
 ;;^UTILITY(U,$J,358.3,30026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30026,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,30026,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,30026,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,30027,0)
 ;;=C90.00^^135^1372^165
 ;;^UTILITY(U,$J,358.3,30027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30027,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,30027,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,30027,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,30028,0)
 ;;=C94.6^^135^1372^166
 ;;^UTILITY(U,$J,358.3,30028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30028,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,30028,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,30028,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,30029,0)
 ;;=D61.82^^135^1372^167
 ;;^UTILITY(U,$J,358.3,30029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30029,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,30029,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,30029,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,30030,0)
 ;;=D47.9^^135^1372^168
 ;;^UTILITY(U,$J,358.3,30030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30030,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,30030,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,30030,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,30031,0)
 ;;=D53.9^^135^1372^172
 ;;^UTILITY(U,$J,358.3,30031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30031,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,30031,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,30031,2)
 ;;=^5002298
